ICAN

Classe 35

Lobbying services, namely, promoting the interests of cancer patients, cancer researchers, cancer treatment providers, and others involved with cancer research, diagnosis and treatment; providing information in the field of patient-payor communications in which information regarding medical billing can be exchanged; providing information in the field of government affairs related to the expanded access to experimental cancer drugs for compassionate use; providing physician and medical specialist referrals to patients fighting chronic diseases and lethal diseases for assisting in the access to second opinions; providing information in the nature of discounts and rebates for cancer patients for diagnostic tests, drugs and medical devices

Classe 36

Charitable fundraising to support providing educational services and information about prevention, screening, diagnosis and treatment of cancer, cancer patient navigation services, cancer patient and clinical trials advocacy programs, research, development and regulatory approval of methods, drugs and devices for prevention, screening, diagnosis and treatment of cancer, lobbying and legislation regarding cancer-related issues, patient-provider communications, and patient-payor communications; providing information concerning the patient's financial reimbursement from medical insurers and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer treatment; providing information regarding insurance coverage and patient assistance programs in the nature of cost-mitigating health reimbursement arrangements for cancer patients for diagnostic tests, drugs and medical devices

Classe 41

Co-sponsoring and providing educational conferences, both live and via telephone conferences, seminars, classes and workshops in the field of cancer-related issues and distribution of educational materials in connection therewith; on-line journals, namely, blogs featuring information in the field of cancer-related issues; providing podcasts and non-downloadable videos in the field of cancer-related issues; providing on-line journals, namely, blogs featuring cancer-related issues and postings in honor of patients and in memory of patients

Classe 42

Providing information in the field of anti-cancer drug discovery and development; providing information in the field of clinical trials

Classe 44

Providing information about prevention, screening, diagnosis and treatment of cancer; providing a website, and links to the websites of others, featuring information about prevention, screening, diagnosis and treatment of cancer; providing information in the field of patient medical information where patients can inquire about medical issues and be directed to resources for medical information customized to their need for information about their condition; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing information in the field of cancer treatment for the benefit of patients and patients' families; providing information in the field of communications between patients and health care providers in which patient medical information can be exchanged; providing information in the field of patient access to diagnostic tests, drugs and medical devices provided by health care facilities; providing information in the field of medicine, personalized medicine, pathology, oncology, interventional radiology, radiogenomics, and anesthesiology; providing information in the field of complementary and alternative medicine for use in the prevention and treatment of cancer; providing access to medical specialists for second opinions for patients fighting chronic diseases and lethal diseases

Classe 45

Providing patient advocacy and patient advocate services in the field of cancer treatment; providing cancer patient advocacy programs; providing advocacy services to potential participants and participants in clinical trials; providing information in the field of personal emotional support of cancer patients and patients' families; providing information in the field of regulatory affairs compliance relating to the approval of anticancer compounds in the U.S. and abroad